Thursday, August 08, 2013 8:40:01 AM
RapiMed(R) Over-the-Counter Product Launch
During 2012, the Company worked in developing and market its RapiMed® pediatric pain and fever reliever over-the-counter product, and anticipates national distribution launch in the second quarter of 2013. In February, the Company obtained positive feedback at the 2013 "Cough/Cold, Analgesics & Allergy EPPS" conference, and received verbal order commitments from 62 of 66 retailers that it met with during the conference. The launch of ScripsAmerica’s unique pain and fever relief product should provide for additional revenue growth as the company focuses on expanding its national distribution through the summer 2013, and gaining market share from McNeil Consumer Healthcare's ‘Tylenol Meltaways'. http://www.rapimeds.com
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM